NSVGF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
May 20 closing price
Capitalization
4.72M
ZYXI
Price
$1.94
Change
-$0.29 (-13.00%)
Updated
Aug 1, 10:57 AM (EDT)
Capitalization
397.95M
83 days until earnings call
Interact to see
Advertisement

NSVGF vs ZYXI

Header iconNSVGF vs ZYXI Comparison
Open Charts NSVGF vs ZYXIBanner chart's image
Nass Vy Gateway
Price$0.01
Change-$0.00 (-0.00%)
Volume$34.5K
Capitalization4.72M
Zynex
Price$1.94
Change-$0.29 (-13.00%)
Volume$600
Capitalization397.95M
NSVGF vs ZYXI Comparison Chart in %
Loading...
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NSVGF vs. ZYXI commentary
Aug 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSVGF is a Hold and ZYXI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 01, 2025
Stock price -- (NSVGF: $0.01 vs. ZYXI: $2.23)
Brand notoriety: NSVGF and ZYXI are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: NSVGF: 100% vs. ZYXI: 90%
Market capitalization -- NSVGF: $4.72M vs. ZYXI: $397.95M
NSVGF [@Medical Distributors] is valued at $4.72M. ZYXI’s [@Medical Distributors] market capitalization is $397.95M. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NSVGF’s FA Score shows that 0 FA rating(s) are green whileZYXI’s FA Score has 0 green FA rating(s).

  • NSVGF’s FA Score: 0 green, 5 red.
  • ZYXI’s FA Score: 0 green, 5 red.
According to our system of comparison, ZYXI is a better buy in the long-term than NSVGF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ZYXI’s TA Score shows that 5 TA indicator(s) are bullish.

  • ZYXI’s TA Score: 5 bullish, 4 bearish.

Price Growth

NSVGF (@Medical Distributors) experienced а 0.00% price change this week, while ZYXI (@Medical Distributors) price change was -11.73% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -1.16%. For the same industry, the average monthly price growth was +4.65%, and the average quarterly price growth was +0.45%.

Reported Earning Dates

ZYXI is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical Distributors (-1.16% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ZYXI($398M) has a higher market cap than NSVGF($4.72M). NSVGF YTD gains are higher at: 0.000 vs. ZYXI (-72.119). ZYXI has higher annual earnings (EBITDA): 17.9M vs. NSVGF (-1.57M). ZYXI has more cash in the bank: 44.6M vs. NSVGF (0). NSVGF has less debt than ZYXI: NSVGF (1.24M) vs ZYXI (76.2M). ZYXI has higher revenues than NSVGF: ZYXI (184M) vs NSVGF (29.5K).
NSVGFZYXINSVGF / ZYXI
Capitalization4.72M398M1%
EBITDA-1.57M17.9M-9%
Gain YTD0.000-72.119-
P/E RatioN/A46.30-
Revenue29.5K184M0%
Total Cash044.6M-
Total Debt1.24M76.2M2%
FUNDAMENTALS RATINGS
NSVGF vs ZYXI: Fundamental Ratings
NSVGF
ZYXI
OUTLOOK RATING
1..100
396
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
7865
P/E GROWTH RATING
1..100
10091
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NSVGF's Valuation (92) in the null industry is in the same range as ZYXI (94) in the Medical Specialties industry. This means that NSVGF’s stock grew similarly to ZYXI’s over the last 12 months.

NSVGF's Profit vs Risk Rating (100) in the null industry is in the same range as ZYXI (100) in the Medical Specialties industry. This means that NSVGF’s stock grew similarly to ZYXI’s over the last 12 months.

ZYXI's SMR Rating (94) in the Medical Specialties industry is in the same range as NSVGF (100) in the null industry. This means that ZYXI’s stock grew similarly to NSVGF’s over the last 12 months.

ZYXI's Price Growth Rating (65) in the Medical Specialties industry is in the same range as NSVGF (78) in the null industry. This means that ZYXI’s stock grew similarly to NSVGF’s over the last 12 months.

ZYXI's P/E Growth Rating (91) in the Medical Specialties industry is in the same range as NSVGF (100) in the null industry. This means that ZYXI’s stock grew similarly to NSVGF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NSVGFZYXI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ZYXI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SEDG25.67-0.14
-0.54%
SolarEdge Technologies
ALC87.55-1.63
-1.83%
Alcon
ZYME12.55-0.40
-3.05%
Zymeworks
BFRG1.37-0.05
-3.19%
Bullfrog AI Holdings
TCX17.25-1.44
-7.70%
Tucows

NSVGF and

Correlation & Price change

A.I.dvisor tells us that NSVGF and SHPMY have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSVGF and SHPMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NSVGF
1D Price
Change %
NSVGF100%
N/A
SHPMY - NSVGF
14%
Poorly correlated
N/A
ZYXI - NSVGF
8%
Poorly correlated
-10.31%
PDRX - NSVGF
8%
Poorly correlated
N/A
SHTDF - NSVGF
4%
Poorly correlated
N/A
AMFPF - NSVGF
1%
Poorly correlated
-22.60%
More

ZYXI and

Correlation & Price change

A.I.dvisor tells us that ZYXI and HSIC have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZYXI and HSIC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZYXI
1D Price
Change %
ZYXI100%
-10.31%
HSIC - ZYXI
27%
Poorly correlated
-2.75%
OMI - ZYXI
16%
Poorly correlated
-2.53%
GEG - ZYXI
11%
Poorly correlated
-2.83%
AMFPF - ZYXI
10%
Poorly correlated
-22.60%
SHTDY - ZYXI
9%
Poorly correlated
-4.38%
More